Accession Number: | 0001209191-21-059996 |
Date: | 2021-10-05 |
Issuer: | NGM BIOPHARMACEUTICALS INC (NGM) |
Original Submission Date: |
LIEU HSIAO D
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-10-05 | M | 2,000 | a | $12.06 | 2,000 | direct | ||
COMMON STOCK | 2021-10-05 | S | 2,000 | d | $22.00 | 0 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 12.06 | 2021-10-05 | deemed execution date | M | 2,000 (d) | 2029-03-18 | common stock 2,000 | $12.06 | 190,000 | direct |
ID | footnote |
---|---|
f1 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on august 24, 2021. |
f2 | the shares subject to the stock option vest over a four-year period measured from the grant date, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. |